AUS
NZ
UK
CA
USA
IND
_07_03_2026_03_50_21_133108.jpg)
Noviqtech Limited (ASX:NVQ) has announced that 95,676,047 unquoted options expired unexercised on 24 June 2026. These options, each with an exercise price of $0.08, have now been removed from the company's issued capital following their expiration. This routine corporate event marks the end of these securities as they were not converted into ordinary shares before the expiry date.
Key Highlights
- Noviqtech Limited (NVQ) disclosed the cessation of 95,676,047 unquoted options on the ASX on 17 July 2026.
- The options expired unexercised on 24 June 2026 with an exercise price of $0.08 each.
- Post-expiry, Noviqtech retains 278,829,951 quoted options expiring 5 March 2028 and 405,402,690 ordinary fully paid shares outstanding.
- Investors should track remaining option classes and ordinary share performance as the company’s capital structure evolves.
Details on Noviqtech's Option Expiry and Its Effects on Capital Structure
Noviqtech Limited has officially informed the ASX about the expiration of a significant block of unquoted equity options. The 95,676,047 options that expired carried an exercise price of $0.08 per share and reached maturity on 24 June 2026. The formal notification was submitted on 17 July 2026, confirming these options have been removed from the issued capital. This expiration represents a notable decrease in outstanding convertible securities, as option holders opted not to exercise their rights before the deadline.
These options expired without any payment consideration, consistent with standard corporate practice when options lapse unexercised. This event simplifies Noviqtech’s capital structure by eliminating nearly 96 million options, providing clearer insight into the company’s equity base for shareholders and potential investors.
Remaining Convertible Securities in Noviqtech's Portfolio After Expiry
Following the expiry, Noviqtech maintains several classes of convertible securities. The company holds 278,829,951 quoted options (NVQOA) expiring on 5 March 2028 with a different exercise price than the expired options. These quoted options remain actively traded on the ASX, offering holders the opportunity to convert into ordinary shares before their 2028 expiry.
Additionally, Noviqtech possesses unquoted options across three classes: 88,000 options expiring 15 September 2026 at $0.16 exercise price, 2,250,000 incentive options with no expiry date specified, and 720,000 options expiring 19 December 2026 at various exercise prices. The company also holds 24,975,000 unquoted options expiring 21 July 2026 at a $0.10 exercise price. These unquoted options are generally part of employee compensation or strategic investor agreements and are not publicly traded.
Current Ordinary Share Capital and Market Position of Noviqtech
Post-expiry, Noviqtech has 405,402,690 ordinary fully paid shares outstanding, which constitute the core equity capital of the company. These shares form the basis of the company’s market capitalization as reported by the ASX. The ordinary shares establish the baseline equity to which convertible securities would convert if exercised, indicating potential dilution scenarios for investors.
Noviqtech’s ordinary shares trade on the ASX under the ticker NVQ, allowing free market transactions. The ASX’s published market capitalization includes both ordinary shares and quoted options, offering a comprehensive view of total equity value. The removal of the expired 95.7 million options reduces potential future dilution but does not affect the current number of ordinary shares.
Schedule of Upcoming Option Expirations and Corporate Actions for Noviqtech
The recent expiry involved NVQAP options on 24 June 2026, which have now been fully removed. Upcoming expirations include NVQAO options at $0.10 exercise price on 21 July 2026, NVQAM options at $0.16 on 15 September 2026, and NVQAT options on 19 December 2026 at various prices. The longest-dated options are the quoted NVQOA class expiring 5 March 2028, giving holders nearly two years to decide on exercising.
Impact of Unexercised Option Expiry on Shareholder Dilution
Options expiring unexercised permanently eliminate potential dilution from those securities. The expiry of 95.7 million options removes a significant layer of possible dilution for existing shareholders, as these options will no longer convert into ordinary shares affecting voting power or earnings per share.
The non-exercise likely reflects that Noviqtech’s share price remained below the $0.08 exercise price during the options’ life, making conversion economically unattractive. This suggests share price performance did not incentivize option holders to convert.
ASX Compliance and Capital Structure Disclosure
Noviqtech complied with ASX Listing Rules and the Corporations Act by lodging an Appendix 3H form to notify the cessation of these securities. The notification, submitted on 17 July 2026 for the 24 June 2026 expiry event, confirms no consideration was paid and that this was a natural expiration rather than a buyback or cancellation. This disclosure ensures the ASX maintains accurate issued capital records and informs the market of changes in the company’s capital structure.
Investment Insights for Noviqtech Shareholders and Option Holders
Investors should closely monitor Noviqtech’s evolving capital structure and upcoming option expirations throughout 2026 and 2027. The large volume of options expiring unexercised indicates challenging market conditions or share price levels. Attention should be given to the quoted NVQOA options expiring in March 2028 to assess whether exercise activity increases or if similar non-exercise patterns persist.
The 2,250,000 unquoted incentive options without specified expiry may vest and become exercisable in the future, potentially diluting shareholders. Investors should seek details on vesting terms and exercise prices. The substantial 278.8 million quoted NVQOA options also represent a significant potential dilution if exercised.
Regulatory and Market Transparency Implications of Option Expiry
The cessation of these options marks an important corporate governance milestone officially recorded by the ASX. Noviqtech’s adherence to continuous disclosure requirements promotes market integrity by providing transparent, reliable information about its capital base. The formal notification creates an auditable record of corporate actions affecting issued capital, supporting investor decision-making.
Future Capital Management and Monitoring Recommendations for Noviqtech Investors
Investors should track upcoming option expiry dates, including the 24,975,000 NVQAO options expiring 21 July 2026, NVQAM options in September 2026, and NVQAT options in December 2026. These milestones will provide insight into option holders’ conversion decisions and market conditions. Noviqtech may also pursue additional capital raising, option issuances, or corporate actions that could impact issued capital.
The NVQOA options expiring in March 2028 represent a key future event. Investors should monitor company performance and share price trends as this date approaches, since favorable conditions could prompt significant option exercises and resultant dilution.
